Lawrence Mertz

Teknisk/Vetenskaplig/F&U Direktör på ACCELERATE DIAGNOSTICS, INC.

64 år

Health Technology

Consumer Services

Profil

Lawrence Mertz currently works at Accelerate Diagnostics, Inc., as Chief Technology Officer from 2022.
Dr. Mertz also formerly worked at Biora Therapeutics, Inc., as Vice President-Research & Development, Engineering and Meridian Bioscience, Inc., as SVP-Clinical Operations, Research & Development from 2018 to 2021.
Dr. Mertz received his undergraduate degree and doctorate degree from State University of New York at Buffalo.

Aktiva positioner av Lawrence Mertz

Företag	Position	Start
ACCELERATE DIAGNOSTICS, INC.	Teknisk/Vetenskaplig/F&U Direktör	2021-05-01

Alla aktiva positioner av Lawrence Mertz

Tidigare kända positioner av Lawrence Mertz

Företag	Position	Slut
MERIDIAN BIOSCIENCE, INC.	Teknisk/Vetenskaplig/F&U Direktör	2021-04-01
BIORA THERAPEUTICS, INC.	Teknisk/Vetenskaplig/F&U Direktör	-

Se detaljerna i Lawrence Mertzs erfarenhet

Lawrence Mertzs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Lawrence Mertzs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Meridian Bioscience, Inc. Meridian Bioscience, Inc. Medical SpecialtiesHealth Technology Operates as a life science company that develops, manufactures, markets and distributes diagnostic products	Health Technology
Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions	Health Technology
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biora Therapeutics, Inc. Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases	Health Technology